Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor.

Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor.

Item
http://www.wikidata.org/entity/Q36705704
Inflammatory Bowel Disease Cohort Studies in Korea: Present and FutureThe risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers.Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel diseaseRisks for opportunistic tuberculosis infection in a cohort of 873 patients with inflammatory bowel disease receiving a tumor necrosis factor-α inhibitor.Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis.Novel treatments for inflammatory bowel disease.Efficacy of Treatment for Latent Tuberculosis in Patients Undergoing Treatment with a Tumor Necrosis Factor Antagonist.Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease
P2860

Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor.

Item
http://www.wikidata.org/entity/Q36705704
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clinical characteristics and t ...... r necrosis factor-α inhibitor.
@ast
Clinical characteristics and t ...... r necrosis factor-α inhibitor.
@en
type
label
Clinical characteristics and t ...... r necrosis factor-α inhibitor.
@ast
Clinical characteristics and t ...... r necrosis factor-α inhibitor.
@en
prefLabel
Clinical characteristics and t ...... r necrosis factor-α inhibitor.
@ast
Clinical characteristics and t ...... r necrosis factor-α inhibitor.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Clinical characteristics and t ...... r necrosis factor-α inhibitor.
@en
P2093
P2860
P304
P31
P356
10.3904/KJIM.2013.28.2.174
P433
P478
P577
P5875
P698
P921
P932